Clinical evaluation of Shenqi Fugan granule for chronic Hepatitis C and its effect on WBC and neutrophil count / 中国生化药物杂志

ABSTRACT

Objective To study the clinical evaluation of Shenqi Fugan granule for chronic Hepatitis C and its effect on WBC and neutrophil count.Methods 135 patients with chronic hepatitis C from October 2014 to September 2016 were randomly divided into control group(n=68)and control group(n=68).The patients in control group were treated with reserpine.The patients in the observation group were treated with Shenqi Fugan Granule,and then the numbers of leukocytes and neutrophils were measured before and after treatment at 2,4 and 8 weeks after treatment.Meanwhile,the patients in both groups were treated before and after treatment.Liver function recovery,and to make a comprehensive evaluation of its clinical effect.Results There were significant differences between the two groups before and after treatment(P<0.05).The difference between the two groups was statistically significant(P<0.05),and the difference between the two groups was statistically significant(P<0.05).After treatment,the liver function(alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TBIL))in the observation group was significantly better than that in the control group,and the total effective rate(91.18％)in the observation group was significantly greater than that in the control group Total effective rate(85.07％),the difference between the two groups was statistically significant(P<0.05).Conclusion The clinical effect of Shenqi Fugan Granule on chronic hepatitis C is significant,which can effectively inhibit the decrease of peripheral white blood cell count and middle cell count,and the safety is higher.